Published in Diabetes Res Clin Pract on January 17, 2012
Evaluating Tools for Health Promotion and Disease Prevention | NCT00164658
Perceptions of family history and genetic testing and feasibility of pedigree development among African Americans with hypertension. Eur J Cardiovasc Nurs (2014) 1.42
Association of weight misperception with weight loss in a diabetes prevention program. BMC Public Health (2014) 0.81
Understanding perceived risk of type 2 diabetes in healthy middle-aged adults: a cross-sectional study of associations with modelled risk, clinical risk factors, and psychological factors. Diabetes Res Clin Pract (2014) 0.80
Impact of family history assessment on communication with family members and health care providers: A report from the Family Healthware™ Impact Trial (FHITr). Prev Med (2015) 0.76
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med (2001) 56.11
Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract (2009) 25.83
The Health Belief Model: a decade later. Health Educ Q (1984) 25.48
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet (2010) 11.55
The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med (1997) 7.65
A meta-analysis of fear appeals: implications for effective public health campaigns. Health Educ Behav (2000) 6.72
International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabet Med (2007) 3.88
Family history: a comprehensive genetic risk assessment method for the chronic conditions of adulthood. Am J Med Genet (1997) 2.79
Family history of diabetes as a potential public health tool. Am J Prev Med (2003) 2.76
Unrealistic optimism about susceptibility to health problems. J Behav Med (1982) 2.47
Family history and prevalence of diabetes in the U.S. population: the 6-year results from the National Health and Nutrition Examination Survey (1999-2004). Diabetes Care (2007) 2.22
Developing Family Healthware, a family history screening tool to prevent common chronic diseases. Prev Chronic Dis (2008) 2.20
Lifestyle interventions reduce coronary heart disease risk: results from the PREMIER Trial. Circulation (2009) 1.94
Effect of preventive messages tailored to family history on health behaviors: the Family Healthware Impact Trial. Ann Fam Med (2011) 1.75
Family history of type 2 diabetes: a population-based screening tool for prevention? Genet Med (2006) 1.67
Familial risk for common diseases in primary care: the Family Healthware Impact Trial. Am J Prev Med (2009) 1.62
Family history, diabetes, and other demographic and risk factors among participants of the National Health and Nutrition Examination Survey 1999-2002. Prev Chronic Dis (2005) 1.45
Family and friends with disease: their impact on perceived risk. Prev Med (2003) 1.31
Lifestyle factors on the risks of ischemic and hemorrhagic stroke. Arch Intern Med (2011) 1.31
Risk and prevention of type II diabetes: offspring's views. Br J Gen Pract (2001) 1.25
Comparison of risk perceptions and beliefs across common chronic diseases. Prev Med (2008) 1.24
Impact of communicating familial risk of diabetes on illness perceptions and self-reported behavioral outcomes: a randomized controlled trial. Diabetes Care (2009) 1.21
Effect of family history of type 2 diabetes on the intima-media thickness of the common carotid artery in normal-weight, overweight, and obese glucose-tolerant young adults. Diabetes Care (2003) 1.19
Detecting undiagnosed type 2 diabetes: family history as a risk factor and screening tool. J Diabetes Sci Technol (2009) 1.19
Preventing type 2 diabetes: perceptions about risk and prevention in a population-based sample of adults > or =45 years of age. Diabetes Care (2001) 1.17
Lifestyle and stroke risk: a review. Curr Opin Neurol (2009) 1.14
How do people with Type 2 diabetes perceive and respond to cardiovascular risk? Diabet Med (2003) 1.14
Family history and perceptions about risk and prevention for chronic diseases in primary care: a report from the family healthware impact trial. Genet Med (2010) 1.12
Physician attitudes and practices and patient awareness of the cardiovascular complications of diabetes. J Am Coll Cardiol (2002) 1.10
Evaluation of family history as a risk factor and screening tool for detecting undiagnosed diabetes in a nationally representative survey population. Genet Med (2006) 1.06
Informing patients of familial diabetes mellitus risk: How do they respond? A cross-sectional survey. BMC Health Serv Res (2008) 1.05
Family history of diabetes: exploring perceptions of people at risk in the Netherlands. Prev Chronic Dis (2009) 1.00
Perceived likelihood of developing diabetes among high-risk Oregonians. Prev Chronic Dis (2005) 0.99
Relation of familial patterns of coronary heart disease, stroke, and diabetes to subclinical atherosclerosis: the multi-ethnic study of atherosclerosis. Genet Med (2008) 0.96
Lifestyle changes can be achieved through counseling and follow-up in first-degree relatives of patients with type 2 diabetes. J Am Diet Assoc (2003) 0.95
Knowledge of risk of developing diabetes mellitus among siblings of Type 2 diabetic patients. Diabet Med (1999) 0.93
Diabetes and the metabolic syndrome--when is it best to intervene to prevent? Atheroscler Suppl (2006) 0.87
Family history of diabetes and risk of atherosclerotic cardiovascular disease in Korean men and women. Atherosclerosis (2007) 0.85
Components of family history associated with women's disease perceptions for cancer: a report from the Family Healthware™ Impact Trial. Genet Med (2011) 0.84
Long-term (1- and 2-year) effects of lifestyle intervention in type 2 diabetes relatives. Diabetes Res Clin Pract (2005) 0.84
Family history of type 2 diabetes is associated with increased carotid artery intimal-medial thickness in Mexican Americans. Diabetes Care (2005) 0.83
Reducing health risk in family members of patients with type 2 diabetes: views of first degree relatives. BMC Public Health (2009) 0.82
Perception of risk of developing diabetes in offspring of type 2 diabetic patients. Korean J Intern Med (2002) 0.80
Preventive behaviour in adult offspring of Type 2 diabetic patients and its relationship to parental advice. Diabet Med (2008) 0.79
Perception of offspring risk for type 2 diabetes among patients with type 2 diabetes and their adult offspring. Diabetes Care (2007) 0.79
ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res (2013) 9.31
Letting the genome out of the bottle--will we get our wish? N Engl J Med (2008) 9.10
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA (2010) 8.93
Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time. Genet Med (2011) 8.48
Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am J Epidemiol (2006) 7.66
Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet (2008) 6.71
The pediatric preclinical testing program: description of models and early testing results. Pediatr Blood Cancer (2007) 5.28
A navigator for human genome epidemiology. Nat Genet (2008) 5.07
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet (2010) 4.96
Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol (2007) 4.96
Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol (2008) 4.53
How many genes underlie the occurrence of common complex diseases in the population? Int J Epidemiol (2005) 4.46
Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes. Am J Hum Genet (2012) 4.45
BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol (2002) 4.38
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet (2012) 4.27
Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Arch Intern Med (2011) 4.22
Can family history be used as a tool for public health and preventive medicine? Genet Med (2002) 3.76
National Institutes of Health approaches to dissemination and implementation science: current and future directions. Am J Public Health (2012) 3.72
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA (2007) 3.62
Dose escalation of a curcuminoid formulation. BMC Complement Altern Med (2006) 3.59
A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet (2008) 3.25
Recommendations for returning genomic incidental findings? We need to talk! Genet Med (2013) 3.23
A road map for efficient and reliable human genome epidemiology. Nat Genet (2006) 3.21
American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. J Clin Oncol (2014) 3.07
What is the clinical utility of genetic testing? Genet Med (2006) 3.01
Research priorities for evaluating family history in the prevention of common chronic diseases. Am J Prev Med (2003) 2.99
New knowledge for and about primary care: a view through the looking glass of the Annals of Family Medicine. Ann Fam Med (2006) 2.81
Improving validation practices in "omics" research. Science (2011) 2.73
Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol (2009) 2.45
Reducing the influence of anecdotal reasoning on people's health care decisions: is a picture worth a thousand statistics? Med Decis Making (2005) 2.43
Family history in public health practice: a genomic tool for disease prevention and health promotion. Annu Rev Public Health (2010) 2.43
STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med (2009) 2.39
The genetic family history as a risk assessment tool in internal medicine. Genet Med (2003) 2.35
The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases. Genet Med (2007) 2.34
Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. Am J Epidemiol (2006) 2.34
Recruitment of minority and underserved populations in the United States: the Centers for Population Health and Health Disparities experience. Contemp Clin Trials (2008) 2.29
Most published research findings are false-but a little replication goes a long way. PLoS Med (2007) 2.26
Family history and prevalence of diabetes in the U.S. population: the 6-year results from the National Health and Nutrition Examination Survey (1999-2004). Diabetes Care (2007) 2.22
Developing Family Healthware, a family history screening tool to prevent common chronic diseases. Prev Chronic Dis (2008) 2.20
Health care provider and consumer awareness, perceptions, and use of direct-to-consumer personal genomic tests, United States, 2008. Genet Med (2009) 2.17
DNA banking for epidemiologic studies: a review of current practices. Epidemiology (2002) 2.16
The path from genome-based research to population health: development of an international public health genomics network. Genet Med (2006) 2.15
Invited commentary: genes, environment, and hybrid vigor. Am J Epidemiol (2009) 2.15
Genomic profiling to promote a healthy lifestyle: not ready for prime time. Nat Genet (2003) 2.11
Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration. Am J Clin Nutr (2003) 2.11
Evolution of the "drivers" of translational cancer epidemiology: analysis of funded grants and the literature. Am J Epidemiol (2015) 2.04
Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev (2008) 1.99
Future health applications of genomics: priorities for communication, behavioral, and social sciences research. Am J Prev Med (2010) 1.98
Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies. Cancer (2007) 1.93
Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Am J Hum Genet (2003) 1.85
Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev (2008) 1.85
Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diabetes Care (2003) 1.84
Genomics and the prevention and control of common chronic diseases: emerging priorities for public health action. Prev Chronic Dis (2005) 1.84
Required sample size and nonreplicability thresholds for heterogeneous genetic associations. Proc Natl Acad Sci U S A (2008) 1.84
Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital. J Pediatr Hematol Oncol (2002) 1.82
STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement. Eur J Clin Invest (2009) 1.82
On the use of population attributable fraction to determine sample size for case-control studies of gene-environment interaction. Epidemiology (2003) 1.82
Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. Am J Prev Med (2011) 1.80
From public health emergency to public health service: the implications of evolving criteria for newborn screening panels. Pediatrics (2006) 1.77
Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention. Genet Med (2006) 1.77
Effect of preventive messages tailored to family history on health behaviors: the Family Healthware Impact Trial. Ann Fam Med (2011) 1.75
GAPscreener: an automatic tool for screening human genetic association literature in PubMed using the support vector machine technique. BMC Bioinformatics (2008) 1.75
The next generation of large-scale epidemiologic research: implications for training cancer epidemiologists. Am J Epidemiol (2014) 1.73
"Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities. Cancer Epidemiol Biomarkers Prev (2013) 1.72
Cancer GAMAdb: database of cancer genetic associations from meta-analyses and genome-wide association studies. Eur J Hum Genet (2011) 1.69
Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut (2007) 1.68
Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am J Epidemiol (2006) 1.67
Family history of type 2 diabetes: a population-based screening tool for prevention? Genet Med (2006) 1.67
Application of support vector machine modeling for prediction of common diseases: the case of diabetes and pre-diabetes. BMC Med Inform Decis Mak (2010) 1.66
Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps. Cancer Prev Res (Phila) (2012) 1.65
Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma. Am J Ophthalmol (2005) 1.64
Familial risk for common diseases in primary care: the Family Healthware Impact Trial. Am J Prev Med (2009) 1.62
Challenges of translating genetic tests into clinical and public health practice. Nat Rev Genet (2009) 1.62
The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology (2007) 1.61
Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo. Clin Cancer Res (2006) 1.58
Tailored interventions for multiple risk behaviors. Health Educ Res (2002) 1.58
Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist. J Clin Oncol (2003) 1.53
Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia. Vaccine (2009) 1.53
Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. Am J Epidemiol (2008) 1.53
Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. Int J Cancer (2005) 1.51
Effects of ginger supplementation on cell-cycle biomarkers in the normal-appearing colonic mucosa of patients at increased risk for colorectal cancer: results from a pilot, randomized, and controlled trial. Cancer Prev Res (Phila) (2013) 1.49
Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer. Clin Trials (2008) 1.48
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet (2009) 1.47
Chromoendoscopy detects more adenomas than colonoscopy using intensive inspection without dye spraying. Cancer Prev Res (Phila) (2008) 1.47
Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration. J Clin Epidemiol (2011) 1.46